E
Emmanuel Houdart
Researcher at University of Paris
Publications - 199
Citations - 10621
Emmanuel Houdart is an academic researcher from University of Paris. The author has contributed to research in topics: Embolization & Aneurysm. The author has an hindex of 39, co-authored 190 publications receiving 9194 citations. Previous affiliations of Emmanuel Houdart include Paris Diderot University & Paris-Sorbonne University.
Papers
More filters
Journal ArticleDOI
Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage.
Christophe Cognard,Y P Gobin,Laurent Pierot,A. L. Bailly,Emmanuel Houdart,Alfredo Casasco,Jacques Chiras,Jean-Jacques Merland +7 more
TL;DR: This classification provides useful data for determination of the risk with each dural AVF and enables decision-making about the appropriate therapy.
Journal ArticleDOI
Arterial embolisation to treat uterine myomata
J. H. Ravina,N. Ciraru-vigneron,Bouret Jm,D. Herbreteau,Emmanuel Houdart,Armand Aymard,Jean-Jacques Merland +6 more
TL;DR: 16 patients, aged 34-48 years, with symptomatic uterine myomata, for which a major surgical procedure was planned after failure of medical treatment, were treated by selective free-flow arterial embolisation of theMyomata with Ivalon particles, with a mean follow-up of 20 months.
Journal ArticleDOI
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial
Jay P. Mohr,Michael K. Parides,Christian Stapf,Christian Stapf,Ellen Moquete,Claudia S. Moy,Jessica Overbey,Rustam Al-Shahi Salman,Eric Vicaut,William L. Young,Emmanuel Houdart,Charlotte Cordonnier,Marco Antonio Stefani,Andreas Hartmann,Rüdiger von Kummer,Alessandra Biondi,Joachim Berkefeld,Catharina J.M. Klijn,Kirsty Harkness,Richard B. Libman,Xavier Barreau,Alan J. Moskowitz +21 more
TL;DR: The ARUBA trial showed that medical management alone is superior to medical management with interventional therapy for the prevention of death or stroke in patients with unruptured brain arteriovenous malformations followed up for 33 months.
Journal ArticleDOI
Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial.
Jean-Louis Mas,Ludovic Trinquart,Didier Leys,Jean-François Albucher,Hervé Rousseau,Alain Viguier,Jean-Pierre Bossavy,Béatrice Denis,Philippe Piquet,Pierre Garnier,Fausto Viader,Emmanuel Touzé,Pierre Julia,Maurice Giroud,Denis Krausé,Hassan Hosseini,Jean-Pierre Becquemin,Grégoire Hinzelin,Emmanuel Houdart,Hilde Hénon,Jean-Philippe Neau,Serge Bracard,Yannick Onnient,Raymond Padovani,Gilles Chatellier +24 more
TL;DR: The results of this study suggest that carotid stenting is as effective ascarotid endarterectomy for middle-term prevention of ipsilateral stroke, but the safety of carotin stenting needs to be improved before it can be used as an alternative to carotids endarteretomy in patients with symptomatic carotID stenosis.
Journal ArticleDOI
Intra-Aneurysmal Thrombosis as a Possible Cause of Delayed Aneurysm Rupture after Flow-Diversion Treatment
Zsolt Kulcsar,Emmanuel Houdart,Alain Bonafe,G. Parker,John Millar,A.J.P. Goddard,S. Renowden,G. Gál,B. Turowski,K. Mitchell,F. Gray,M. Rodriguez,R. van den Berg,Andreas Gruber,Hubert Desal,Isabel Wanke,Daniel A. Rüfenacht +16 more
TL;DR: FDs alone may modify hemodynamics in ways that induce extensive aneurysm thrombosis under specific conditions, however, instead of reverse remodeling and cicatrization, aggressive thrombus-associated autolysis of the aneurYSm wall may result in delayed rupture.